{"mainPropery":{"diseaseId":5854,"diseaseName":"Aspartylglycosaminuria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5854/aspartylglycosaminuria","synonyms":["Aspartylglucosaminuria","Aspartylglucosamidase (AGA) deficiency","AGU","AGA deficiency","Glycosylasparaginase deficiency"],"synonyms-with-source":[{"name":"Aspartylglucosaminuria"},{"name":"Aspartylglucosamidase (AGA) deficiency"},{"name":"AGU"},{"name":"AGA deficiency"},{"name":"Glycosylasparaginase deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"208400"},{"identifierType":"ORPHANET","identifierId":"93"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""},{"resourceID":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","abbreviation":"","address1":"20880 Canyon View Drive","address2":"","address3":"","address4":"","address5":"","city":"Saratoga","state":"CA","zip":"95070","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@ismrd.org","url":"https://www.ismrd.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/208400' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=208400' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Aspartylglycosaminuria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Aspartylglycosaminuria%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Aspartylglycosaminuria. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Aspartylglycosaminuria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":267,"resourceId":1104,"resourceName":"American Society of Gene & Cell Therapy -Disease treatment","descriptionText":"The <a href='https://www.asgct.org/education' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":282,"resourceId":748,"resourceName":"The International Advocates for Glycoprotein Storage Diseases (ISMRD)","descriptionText":"<a href='http://www.ismrd.org/5th_family_workshop/overview ' target='_blank'>2012 International Conference for Glycoprotein Storage Diseases</a>, July 27, 2012 - July 30, 2012<br /><strong>Location</strong>: Crowne Plaza Hotel, Charleston, SC<br /><strong>Description</strong>: The International Society for Mannosidosis &amp; Related Storage Diseases (ISMRD) is sponsoring the 2012 International Conference for Glycoprotein Storage Diseases. The Scientific/Family meetings will be held concurrently on July 28th and 29th. Alongside this meeting, they are hosting the extension of the Natural History Study, with clinic days on July 27th and 30th.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/ldn' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/CN029333' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/918/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=93' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:208400' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":5079,"questionText":"What is aspartylglycosaminuria?","answerText":"<strong>Aspartylglycosaminuria</strong> is&nbsp;a very rare&nbsp;lysosomal storage disease that causes a progressive decline in mental functioning. Infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3.&nbsp;Major symptoms may include coarse facial features, spine and eye deformities, behavior problems, and <a href=\"http://nichcy.org/disability/specific/intellectual\" target=_blank>intellectual disability</a>.&nbsp; Symptoms&nbsp;result from&nbsp;a deficiency in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=_blank>enzyme</a>&nbsp;called aspartylglycosaminidase, which leads to&nbsp;an accumulation of a protein called glycoasparagine in the body tissues and&nbsp; increased excretion of this protein in the urine.&nbsp;Aspartylglycosaminuria is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> fashion and caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/AGA\" target=_blank>AGA</a></em> gene. It is commonly seen in individuals of Finnish decent.[4106][4107][4108]","dateModified":"2011-08-17T12:43:00"},"basicQuestions":[{"questionId":5080,"questionText":"What are the signs and symptoms of aspartylglycosaminuria?","answerText":"Infants with aspartylglycosaminuria appear healthy at birth, and development is typcailly normal throughout childhood. The first sign of this condition, which becomes evident around the age of 2 or 3, is usually delayed speech. Mild intellectual disability then becomes apparent, and learning occurs at a slowed pace. Intellectual disability progressively worsens in adolescence. Most people with this disorder lose much of the speech they have learned, and affected adults usually have only a few words in their vocabulary. Adults with aspartylglucosaminuria may develop <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>&nbsp;or problems with movement.[4108] <br><br>People with this condition may also have bones that become progressively weak and prone to fracture (<a href=\"http://www.nlm.nih.gov/medlineplus/osteoporosis.html\" target=_blank>osteoporosis</a>), an unusually large range of joint movement (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003295.htm\" target=_blank>hypermobility</a>), and loose skin. Affected individuals tend to have a characteristic facial appearance that includes widely spaced eyes (<a href=\"https://www.childrens.com/specialties-services/specialty-centers-and-programs/plastic-craniofacial-surgery/programs-and-services/craniofacial-program/conditions-and-treatments/hypertelorism\" target=_blank>ocular hypertelorism</a>), small ears, and full lips. The nose is short and broad and the face is usually square-shaped. Children with this condition may be tall for their age, but lack of a growth spurt in puberty typically causes adults to be short. Affected children also tend to have frequent upper respiratory infections. Individuals with aspartylglucosaminuria usually survive into mid-adulthood.[4108] The skeleton may also become deformed. The spine may be twisted (<a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\">scoliosis</a>) and the neck may be unusually short. The&nbsp;eyes&nbsp;may also develop <a href=\"http://www.nlm.nih.gov/medlineplus/cataract.html\" target=_blank>cataracts</a>. Behavior problems are common. Lung, heart and blood problems tend to occur in later years.[4107]","dateModified":"2011-08-17T12:57:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4107,"authors":"","articleTitle":"Aspartylglycosaminuria ","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2004","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/918/viewAbstract","dateAccessed":"2011-08-17T00:00:00"},{"referenceId":4108,"authors":"","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December 2008","url":"http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria","dateAccessed":"2011-08-17T00:00:00"}]},{"questionId":5081,"questionText":"How is&nbsp;aspartylglycosaminuria inherited?","answerText":"This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[4108]","dateModified":"2011-08-17T12:46:00","resourceClassificationName":"Inheritance","references":[{"referenceId":4108,"authors":"","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December 2008","url":"http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria","dateAccessed":"2011-08-17T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":31858,"abbreviatedInquiry":"Both my brother and sister have&nbsp;aspartylglycosaminuria. I would like to get in contact with other families that have this&nbsp;illness.&nbsp;Also, can you provide some information on it? ","caseQuestions":[{"questionId":5079,"questionText":"What is aspartylglycosaminuria?","answerText":"<strong>Aspartylglycosaminuria</strong> is&nbsp;a very rare&nbsp;lysosomal storage disease that causes a progressive decline in mental functioning. Infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3.&nbsp;Major symptoms may include coarse facial features, spine and eye deformities, behavior problems, and <a href=\"http://nichcy.org/disability/specific/intellectual\" target=_blank>intellectual disability</a>.&nbsp; Symptoms&nbsp;result from&nbsp;a deficiency in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=_blank>enzyme</a>&nbsp;called aspartylglycosaminidase, which leads to&nbsp;an accumulation of a protein called glycoasparagine in the body tissues and&nbsp; increased excretion of this protein in the urine.&nbsp;Aspartylglycosaminuria is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> fashion and caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/AGA\" target=_blank>AGA</a></em> gene. It is commonly seen in individuals of Finnish decent.[4106][4107][4108]","dateModified":"2011-08-17T12:43:00","references":[{"referenceId":4106,"authors":"Froissart R & Maire I","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Orphanet","date":"February 2005","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=93","dateAccessed":"2011-08-17T00:00:00"},{"referenceId":4107,"authors":"","articleTitle":"Aspartylglycosaminuria ","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2004","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/918/viewAbstract","dateAccessed":"2011-08-17T00:00:00"},{"referenceId":4108,"authors":"","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December 2008","url":"http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria","dateAccessed":"2011-08-17T00:00:00"}]},{"questionId":5080,"questionText":"What are the signs and symptoms of aspartylglycosaminuria?","answerText":"Infants with aspartylglycosaminuria appear healthy at birth, and development is typcailly normal throughout childhood. The first sign of this condition, which becomes evident around the age of 2 or 3, is usually delayed speech. Mild intellectual disability then becomes apparent, and learning occurs at a slowed pace. Intellectual disability progressively worsens in adolescence. Most people with this disorder lose much of the speech they have learned, and affected adults usually have only a few words in their vocabulary. Adults with aspartylglucosaminuria may develop <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=_blank>seizures</a>&nbsp;or problems with movement.[4108] <br><br>People with this condition may also have bones that become progressively weak and prone to fracture (<a href=\"http://www.nlm.nih.gov/medlineplus/osteoporosis.html\" target=_blank>osteoporosis</a>), an unusually large range of joint movement (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003295.htm\" target=_blank>hypermobility</a>), and loose skin. Affected individuals tend to have a characteristic facial appearance that includes widely spaced eyes (<a href=\"https://www.childrens.com/specialties-services/specialty-centers-and-programs/plastic-craniofacial-surgery/programs-and-services/craniofacial-program/conditions-and-treatments/hypertelorism\" target=_blank>ocular hypertelorism</a>), small ears, and full lips. The nose is short and broad and the face is usually square-shaped. Children with this condition may be tall for their age, but lack of a growth spurt in puberty typically causes adults to be short. Affected children also tend to have frequent upper respiratory infections. Individuals with aspartylglucosaminuria usually survive into mid-adulthood.[4108] The skeleton may also become deformed. The spine may be twisted (<a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\">scoliosis</a>) and the neck may be unusually short. The&nbsp;eyes&nbsp;may also develop <a href=\"http://www.nlm.nih.gov/medlineplus/cataract.html\" target=_blank>cataracts</a>. Behavior problems are common. Lung, heart and blood problems tend to occur in later years.[4107]","dateModified":"2011-08-17T12:57:00","resourceClassificationName":"Symptoms","references":[{"referenceId":4107,"authors":"","articleTitle":"Aspartylglycosaminuria ","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2004","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/918/viewAbstract","dateAccessed":"2011-08-17T00:00:00"},{"referenceId":4108,"authors":"","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December 2008","url":"http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria","dateAccessed":"2011-08-17T00:00:00"}]},{"questionId":5081,"questionText":"How is&nbsp;aspartylglycosaminuria inherited?","answerText":"This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[4108]","dateModified":"2011-08-17T12:46:00","resourceClassificationName":"Inheritance","references":[{"referenceId":4108,"authors":"","articleTitle":"Aspartylglucosaminuria","bookWebsiteJournalTitle":"Genetics Home Reference","date":"December 2008","url":"http://ghr.nlm.nih.gov/condition/aspartylglucosaminuria","dateAccessed":"2011-08-17T00:00:00"}]},{"questionId":5082,"questionText":"How can I get in contact with other families with&nbsp;aspartylglycosaminuria?","answerText":"You you can <a href=\"https://rarediseases.info.nih.gov/gard/5854/aspartylglycosaminuria/resources/5\" target=\"_blank\">view our Organizations page for this condition</a> to find advocacy organizations that provide information and supportive resources. They may be able to assist you in connecting with other families with aspartylglycosaminuria.","dateModified":"2011-08-17T12:52:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3619,"phenoTypeName":"Abnormality of amino acid metabolism","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1702,"phenoTypeName":"Aspartylglucosaminuria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":149,"phenoTypeName":"Dyskinesia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14208,"phenoTypeName":"Gingival overgrowth","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10388,"phenoTypeName":"Hypertelorism","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11812,"phenoTypeName":"Large face","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10381,"phenoTypeName":"Mandibular prognathia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6159,"phenoTypeName":"Microtia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14499,"phenoTypeName":"Short nose","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15422,"phenoTypeName":"Thick vermilion border","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4092,"phenoTypeName":"Umbilical hernia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10447,"phenoTypeName":"Wide nasal bridge","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14487,"phenoTypeName":"Abnormal cortical bone morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8872,"phenoTypeName":"Abnormality of the ulna","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13356,"phenoTypeName":"Anterior beaking of lumbar vertebrae","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10149,"phenoTypeName":"Carious teeth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9753,"phenoTypeName":"Macroglossia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6453,"phenoTypeName":"Macroorchidism","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14140,"phenoTypeName":"Pectus carinatum","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13309,"phenoTypeName":"Thickened calvaria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11326,"phenoTypeName":"Chronic otitis media","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10703,"phenoTypeName":"Delayed skeletal maturation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6359,"phenoTypeName":"Inguinal hernia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5683,"phenoTypeName":"Joint stiffness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3900,"phenoTypeName":"Pes planus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4379,"phenoTypeName":"Vascular skin abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","percentRanges":"-"},{"phenoTypeId":9328,"phenoTypeName":"Acne","percentRanges":"-"},{"phenoTypeId":9304,"phenoTypeName":"Angiokeratoma corporis diffusum","percentRanges":"-"},{"phenoTypeId":10462,"phenoTypeName":"Anteverted nares","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10759,"phenoTypeName":"Beaking of vertebral bodies","percentRanges":"-"},{"phenoTypeId":9833,"phenoTypeName":"Brachycephaly","percentRanges":"-"},{"phenoTypeId":9879,"phenoTypeName":"Broad face","percentRanges":"-"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","percentRanges":"-"},{"phenoTypeId":13447,"phenoTypeName":"Cerebral atrophy","percentRanges":"-"},{"phenoTypeId":8960,"phenoTypeName":"Decreased prothrombin time","percentRanges":"-"},{"phenoTypeId":11344,"phenoTypeName":"Depressed nasal bridge","percentRanges":"-"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":10270,"phenoTypeName":"Dysostosis multiplex","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":1860,"phenoTypeName":"Hernia","percentRanges":"-"},{"phenoTypeId":4766,"phenoTypeName":"Hoarse voice","percentRanges":"-"},{"phenoTypeId":10689,"phenoTypeName":"Hypoplastic frontal sinuses","percentRanges":"-"},{"phenoTypeId":5688,"phenoTypeName":"Joint laxity","percentRanges":"-"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","percentRanges":"-"},{"phenoTypeId":9844,"phenoTypeName":"Microcephaly","percentRanges":"-"},{"phenoTypeId":8979,"phenoTypeName":"Mitral regurgitation","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","percentRanges":"-"},{"phenoTypeId":10709,"phenoTypeName":"Pathologic fracture","percentRanges":"-"},{"phenoTypeId":10254,"phenoTypeName":"Platyspondyly","percentRanges":"-"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","percentRanges":"-"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","percentRanges":"-"},{"phenoTypeId":10989,"phenoTypeName":"Spondylolisthesis","percentRanges":"-"},{"phenoTypeId":10990,"phenoTypeName":"Spondylolysis","percentRanges":"-"},{"phenoTypeId":9781,"phenoTypeName":"Thick lower lip vermilion","percentRanges":"-"},{"phenoTypeId":15556,"phenoTypeName":"Vacuolated lymphocytes","percentRanges":"-"},{"phenoTypeId":9750,"phenoTypeName":"Wide mouth","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Aspartylglycosaminuria"}